HEADER IMMUNE SYSTEM 13-MAR-18 6CPO TITLE CRYSTAL STRUCTURE OF DR15 PRESENTING THE RQ13 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN; COMPND 3 CHAIN: A, D; COMPND 4 SYNONYM: MHC CLASS II ANTIGEN DRA; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HLA-DRB1 PROTEIN; COMPND 8 CHAIN: B, E; COMPND 9 SYNONYM: MHC CLASS II ANTIGEN; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: RQ13; COMPND 13 CHAIN: C, F; COMPND 14 SYNONYM: PR55GAG; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-DRA, HLA-DRA1; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: HLA-DRB1; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: HIV-1 M:B_HXB2R; SOURCE 18 ORGANISM_TAXID: 11706 KEYWDS IMMUNE RECEPTOR, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR C.FARENC,S.GRAS,J.ROSSJOHN REVDAT 4 04-OCT-23 6CPO 1 HETSYN REVDAT 3 29-JUL-20 6CPO 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE REVDAT 2 27-JUN-18 6CPO 1 TITLE JRNL REVDAT 1 06-JUN-18 6CPO 0 JRNL AUTH M.GALPERIN,C.FARENC,M.MUKHOPADHYAY,D.JAYASINGHE,A.DECROOS, JRNL AUTH 2 D.BENATI,L.L.TAN,L.CIACCHI,H.H.REID,J.ROSSJOHN, JRNL AUTH 3 L.A.CHAKRABARTI,S.GRAS JRNL TITL CD4+T CELL-MEDIATED HLA CLASS II CROSS-RESTRICTION IN HIV JRNL TITL 2 CONTROLLERS. JRNL REF SCI IMMUNOL V. 3 2018 JRNL REFN ESSN 2470-9468 JRNL PMID 29884618 JRNL DOI 10.1126/SCIIMMUNOL.AAT0687 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.08 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 34562 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 1707 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 17 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.47 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.93 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2984 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2380 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2818 REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE : 0.2850 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.56 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 166 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6275 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 278 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.08 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.74070 REMARK 3 B22 (A**2) : -3.48990 REMARK 3 B33 (A**2) : -1.25080 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.10100 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.320 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.438 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.254 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.442 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.258 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.920 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.887 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6540 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8905 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2238 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 183 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 940 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6540 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 823 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7191 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 0.99 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.84 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.90 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6CPO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1000233187. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-APR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34562 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 48.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 9.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 4MDO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PBS PH 7.5, NA ACETATE, PEG 4000, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.75000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18700 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 1 REMARK 465 LYS A 2 REMARK 465 GLU A 3 REMARK 465 THR A 182 REMARK 465 GLY B 1 REMARK 465 ILE D 1 REMARK 465 LYS D 2 REMARK 465 THR D 182 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 38 -152.87 -103.93 REMARK 500 LYS A 39 46.33 -144.35 REMARK 500 TYR B 78 -59.56 -120.64 REMARK 500 THR B 90 -71.14 -120.74 REMARK 500 LEU B 109 -0.28 -143.65 REMARK 500 HIS B 112 106.91 -55.10 REMARK 500 TRP B 153 30.27 71.97 REMARK 500 TYR E 78 -59.70 -120.32 REMARK 500 THR E 90 -71.25 -120.27 REMARK 500 LEU E 109 -0.32 -145.88 REMARK 500 HIS E 112 107.24 -59.91 REMARK 500 REMARK 500 REMARK: NULL DBREF 6CPO A 1 182 UNP P01903 DRA_HUMAN 26 207 DBREF 6CPO B 1 190 UNP D7RIH9 D7RIH9_HUMAN 30 219 DBREF 6CPO C 89 101 UNP P04591 GAG_HV1H2 299 311 DBREF 6CPO D 1 182 UNP P01903 DRA_HUMAN 26 207 DBREF 6CPO E 1 190 UNP D7RIH9 D7RIH9_HUMAN 30 219 DBREF 6CPO F 89 101 UNP P04591 GAG_HV1H2 299 311 SEQADV 6CPO THR A 182 UNP P01903 ALA 207 CONFLICT SEQADV 6CPO THR D 182 UNP P01903 ALA 207 CONFLICT SEQRES 1 A 182 ILE LYS GLU GLU HIS VAL ILE ILE GLN ALA GLU PHE TYR SEQRES 2 A 182 LEU ASN PRO ASP GLN SER GLY GLU PHE MET PHE ASP PHE SEQRES 3 A 182 ASP GLY ASP GLU ILE PHE HIS VAL ASP MET ALA LYS LYS SEQRES 4 A 182 GLU THR VAL TRP ARG LEU GLU GLU PHE GLY ARG PHE ALA SEQRES 5 A 182 SER PHE GLU ALA GLN GLY ALA LEU ALA ASN ILE ALA VAL SEQRES 6 A 182 ASP LYS ALA ASN LEU GLU ILE MET THR LYS ARG SER ASN SEQRES 7 A 182 TYR THR PRO ILE THR ASN VAL PRO PRO GLU VAL THR VAL SEQRES 8 A 182 LEU THR ASN SER PRO VAL GLU LEU ARG GLU PRO ASN VAL SEQRES 9 A 182 LEU ILE CYS PHE ILE ASP LYS PHE THR PRO PRO VAL VAL SEQRES 10 A 182 ASN VAL THR TRP LEU ARG ASN GLY LYS PRO VAL THR THR SEQRES 11 A 182 GLY VAL SER GLU THR VAL PHE LEU PRO ARG GLU ASP HIS SEQRES 12 A 182 LEU PHE ARG LYS PHE HIS TYR LEU PRO PHE LEU PRO SER SEQRES 13 A 182 THR GLU ASP VAL TYR ASP CYS ARG VAL GLU HIS TRP GLY SEQRES 14 A 182 LEU ASP GLU PRO LEU LEU LYS HIS TRP GLU PHE ASP THR SEQRES 1 B 190 GLY ASP THR ARG PRO ARG PHE LEU TRP GLN PRO LYS ARG SEQRES 2 B 190 GLU CYS HIS PHE PHE ASN GLY THR GLU ARG VAL ARG PHE SEQRES 3 B 190 LEU ASP ARG TYR PHE TYR ASN GLN GLU GLU SER VAL ARG SEQRES 4 B 190 PHE ASP SER ASP VAL GLY GLU PHE ARG ALA VAL THR GLU SEQRES 5 B 190 LEU GLY ARG PRO ASP ALA GLU TYR TRP ASN SER GLN LYS SEQRES 6 B 190 ASP ILE LEU GLU GLN ALA ARG ALA ALA VAL ASP THR TYR SEQRES 7 B 190 CYS ARG HIS ASN TYR GLY VAL GLY GLU SER PHE THR VAL SEQRES 8 B 190 GLN ARG ARG VAL GLN PRO LYS VAL THR VAL TYR PRO SER SEQRES 9 B 190 LYS THR GLN PRO LEU GLN HIS HIS ASN LEU LEU VAL CYS SEQRES 10 B 190 SER VAL SER GLY PHE TYR PRO GLY SER ILE GLU VAL ARG SEQRES 11 B 190 TRP PHE LEU ASN GLY GLN GLU GLU LYS ALA GLY MET VAL SEQRES 12 B 190 SER THR GLY LEU ILE GLN ASN GLY ASP TRP THR PHE GLN SEQRES 13 B 190 THR LEU VAL MET LEU GLU THR VAL PRO ARG SER GLY GLU SEQRES 14 B 190 VAL TYR THR CYS GLN VAL GLU HIS PRO SER VAL THR SER SEQRES 15 B 190 PRO LEU THR VAL GLU TRP ARG ALA SEQRES 1 C 13 ARG PHE TYR LYS THR LEU ARG ALA GLU GLN ALA SER GLN SEQRES 1 D 182 ILE LYS GLU GLU HIS VAL ILE ILE GLN ALA GLU PHE TYR SEQRES 2 D 182 LEU ASN PRO ASP GLN SER GLY GLU PHE MET PHE ASP PHE SEQRES 3 D 182 ASP GLY ASP GLU ILE PHE HIS VAL ASP MET ALA LYS LYS SEQRES 4 D 182 GLU THR VAL TRP ARG LEU GLU GLU PHE GLY ARG PHE ALA SEQRES 5 D 182 SER PHE GLU ALA GLN GLY ALA LEU ALA ASN ILE ALA VAL SEQRES 6 D 182 ASP LYS ALA ASN LEU GLU ILE MET THR LYS ARG SER ASN SEQRES 7 D 182 TYR THR PRO ILE THR ASN VAL PRO PRO GLU VAL THR VAL SEQRES 8 D 182 LEU THR ASN SER PRO VAL GLU LEU ARG GLU PRO ASN VAL SEQRES 9 D 182 LEU ILE CYS PHE ILE ASP LYS PHE THR PRO PRO VAL VAL SEQRES 10 D 182 ASN VAL THR TRP LEU ARG ASN GLY LYS PRO VAL THR THR SEQRES 11 D 182 GLY VAL SER GLU THR VAL PHE LEU PRO ARG GLU ASP HIS SEQRES 12 D 182 LEU PHE ARG LYS PHE HIS TYR LEU PRO PHE LEU PRO SER SEQRES 13 D 182 THR GLU ASP VAL TYR ASP CYS ARG VAL GLU HIS TRP GLY SEQRES 14 D 182 LEU ASP GLU PRO LEU LEU LYS HIS TRP GLU PHE ASP THR SEQRES 1 E 190 GLY ASP THR ARG PRO ARG PHE LEU TRP GLN PRO LYS ARG SEQRES 2 E 190 GLU CYS HIS PHE PHE ASN GLY THR GLU ARG VAL ARG PHE SEQRES 3 E 190 LEU ASP ARG TYR PHE TYR ASN GLN GLU GLU SER VAL ARG SEQRES 4 E 190 PHE ASP SER ASP VAL GLY GLU PHE ARG ALA VAL THR GLU SEQRES 5 E 190 LEU GLY ARG PRO ASP ALA GLU TYR TRP ASN SER GLN LYS SEQRES 6 E 190 ASP ILE LEU GLU GLN ALA ARG ALA ALA VAL ASP THR TYR SEQRES 7 E 190 CYS ARG HIS ASN TYR GLY VAL GLY GLU SER PHE THR VAL SEQRES 8 E 190 GLN ARG ARG VAL GLN PRO LYS VAL THR VAL TYR PRO SER SEQRES 9 E 190 LYS THR GLN PRO LEU GLN HIS HIS ASN LEU LEU VAL CYS SEQRES 10 E 190 SER VAL SER GLY PHE TYR PRO GLY SER ILE GLU VAL ARG SEQRES 11 E 190 TRP PHE LEU ASN GLY GLN GLU GLU LYS ALA GLY MET VAL SEQRES 12 E 190 SER THR GLY LEU ILE GLN ASN GLY ASP TRP THR PHE GLN SEQRES 13 E 190 THR LEU VAL MET LEU GLU THR VAL PRO ARG SER GLY GLU SEQRES 14 E 190 VAL TYR THR CYS GLN VAL GLU HIS PRO SER VAL THR SER SEQRES 15 E 190 PRO LEU THR VAL GLU TRP ARG ALA SEQRES 1 F 13 ARG PHE TYR LYS THR LEU ARG ALA GLU GLN ALA SER GLN HET NAG A 201 14 HET NAG A 202 14 HET PGE A 203 10 HET PO4 B 201 5 HET NAG D 201 14 HET NAG D 202 14 HET PO4 E 201 5 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM PGE TRIETHYLENE GLYCOL HETNAM PO4 PHOSPHATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 7 NAG 4(C8 H15 N O6) FORMUL 9 PGE C6 H14 O4 FORMUL 10 PO4 2(O4 P 3-) FORMUL 14 HOH *278(H2 O) HELIX 1 AA1 GLU A 47 ALA A 52 1 6 HELIX 2 AA2 GLU A 55 SER A 77 1 23 HELIX 3 AA3 THR B 51 LEU B 53 5 3 HELIX 4 AA4 GLY B 54 GLN B 64 1 11 HELIX 5 AA5 GLN B 64 TYR B 78 1 15 HELIX 6 AA6 TYR B 78 GLU B 87 1 10 HELIX 7 AA7 GLU D 47 ALA D 52 1 6 HELIX 8 AA8 GLU D 55 SER D 77 1 23 HELIX 9 AA9 THR E 51 LEU E 53 5 3 HELIX 10 AB1 GLY E 54 GLN E 64 1 11 HELIX 11 AB2 GLN E 64 TYR E 78 1 15 HELIX 12 AB3 TYR E 78 GLU E 87 1 10 SHEET 1 AA1 8 GLU A 40 TRP A 43 0 SHEET 2 AA1 8 ASP A 29 ASP A 35 -1 N HIS A 33 O VAL A 42 SHEET 3 AA1 8 SER A 19 PHE A 26 -1 N PHE A 26 O ASP A 29 SHEET 4 AA1 8 HIS A 5 ASN A 15 -1 N LEU A 14 O SER A 19 SHEET 5 AA1 8 PHE B 7 PHE B 18 -1 O PHE B 17 N HIS A 5 SHEET 6 AA1 8 ARG B 23 TYR B 32 -1 O PHE B 31 N GLN B 10 SHEET 7 AA1 8 GLU B 35 ASP B 41 -1 O GLU B 35 N TYR B 32 SHEET 8 AA1 8 PHE B 47 ALA B 49 -1 O ARG B 48 N ARG B 39 SHEET 1 AA2 4 GLU A 88 THR A 93 0 SHEET 2 AA2 4 ASN A 103 PHE A 112 -1 O ILE A 106 N LEU A 92 SHEET 3 AA2 4 PHE A 145 PHE A 153 -1 O HIS A 149 N CYS A 107 SHEET 4 AA2 4 SER A 133 GLU A 134 -1 N SER A 133 O TYR A 150 SHEET 1 AA3 4 GLU A 88 THR A 93 0 SHEET 2 AA3 4 ASN A 103 PHE A 112 -1 O ILE A 106 N LEU A 92 SHEET 3 AA3 4 PHE A 145 PHE A 153 -1 O HIS A 149 N CYS A 107 SHEET 4 AA3 4 LEU A 138 PRO A 139 -1 N LEU A 138 O ARG A 146 SHEET 1 AA4 4 LYS A 126 PRO A 127 0 SHEET 2 AA4 4 ASN A 118 ARG A 123 -1 N ARG A 123 O LYS A 126 SHEET 3 AA4 4 TYR A 161 GLU A 166 -1 O ARG A 164 N THR A 120 SHEET 4 AA4 4 LEU A 174 TRP A 178 -1 O LEU A 174 N VAL A 165 SHEET 1 AA5 4 LYS B 98 SER B 104 0 SHEET 2 AA5 4 LEU B 114 PHE B 122 -1 O SER B 120 N LYS B 98 SHEET 3 AA5 4 PHE B 155 GLU B 162 -1 O LEU B 161 N LEU B 115 SHEET 4 AA5 4 MET B 142 SER B 144 -1 N VAL B 143 O MET B 160 SHEET 1 AA6 4 LYS B 98 SER B 104 0 SHEET 2 AA6 4 LEU B 114 PHE B 122 -1 O SER B 120 N LYS B 98 SHEET 3 AA6 4 PHE B 155 GLU B 162 -1 O LEU B 161 N LEU B 115 SHEET 4 AA6 4 ILE B 148 GLN B 149 -1 N ILE B 148 O GLN B 156 SHEET 1 AA7 4 GLN B 136 GLU B 137 0 SHEET 2 AA7 4 GLU B 128 LEU B 133 -1 N LEU B 133 O GLN B 136 SHEET 3 AA7 4 VAL B 170 GLU B 176 -1 O GLN B 174 N ARG B 130 SHEET 4 AA7 4 LEU B 184 ARG B 189 -1 O LEU B 184 N VAL B 175 SHEET 1 AA8 8 GLU D 40 TRP D 43 0 SHEET 2 AA8 8 ASP D 29 ASP D 35 -1 N HIS D 33 O VAL D 42 SHEET 3 AA8 8 SER D 19 PHE D 26 -1 N PHE D 26 O ASP D 29 SHEET 4 AA8 8 HIS D 5 ASN D 15 -1 N ILE D 8 O ASP D 25 SHEET 5 AA8 8 PHE E 7 PHE E 18 -1 O PHE E 17 N HIS D 5 SHEET 6 AA8 8 ARG E 23 TYR E 32 -1 O LEU E 27 N GLU E 14 SHEET 7 AA8 8 GLU E 35 ASP E 41 -1 O GLU E 35 N TYR E 32 SHEET 8 AA8 8 PHE E 47 ALA E 49 -1 O ARG E 48 N ARG E 39 SHEET 1 AA9 4 GLU D 88 THR D 93 0 SHEET 2 AA9 4 ASN D 103 PHE D 112 -1 O ILE D 106 N LEU D 92 SHEET 3 AA9 4 PHE D 145 PHE D 153 -1 O HIS D 149 N CYS D 107 SHEET 4 AA9 4 SER D 133 GLU D 134 -1 N SER D 133 O TYR D 150 SHEET 1 AB1 4 GLU D 88 THR D 93 0 SHEET 2 AB1 4 ASN D 103 PHE D 112 -1 O ILE D 106 N LEU D 92 SHEET 3 AB1 4 PHE D 145 PHE D 153 -1 O HIS D 149 N CYS D 107 SHEET 4 AB1 4 LEU D 138 PRO D 139 -1 N LEU D 138 O ARG D 146 SHEET 1 AB2 4 LYS D 126 PRO D 127 0 SHEET 2 AB2 4 ASN D 118 ARG D 123 -1 N ARG D 123 O LYS D 126 SHEET 3 AB2 4 TYR D 161 GLU D 166 -1 O ARG D 164 N THR D 120 SHEET 4 AB2 4 LEU D 174 TRP D 178 -1 O LEU D 174 N VAL D 165 SHEET 1 AB3 4 LYS E 98 SER E 104 0 SHEET 2 AB3 4 LEU E 114 PHE E 122 -1 O SER E 120 N LYS E 98 SHEET 3 AB3 4 PHE E 155 GLU E 162 -1 O LEU E 161 N LEU E 115 SHEET 4 AB3 4 MET E 142 SER E 144 -1 N VAL E 143 O MET E 160 SHEET 1 AB4 4 LYS E 98 SER E 104 0 SHEET 2 AB4 4 LEU E 114 PHE E 122 -1 O SER E 120 N LYS E 98 SHEET 3 AB4 4 PHE E 155 GLU E 162 -1 O LEU E 161 N LEU E 115 SHEET 4 AB4 4 ILE E 148 GLN E 149 -1 N ILE E 148 O GLN E 156 SHEET 1 AB5 4 GLN E 136 GLU E 137 0 SHEET 2 AB5 4 GLU E 128 LEU E 133 -1 N LEU E 133 O GLN E 136 SHEET 3 AB5 4 VAL E 170 GLU E 176 -1 O GLU E 176 N GLU E 128 SHEET 4 AB5 4 LEU E 184 ARG E 189 -1 O TRP E 188 N TYR E 171 SSBOND 1 CYS A 107 CYS A 163 1555 1555 2.03 SSBOND 2 CYS B 15 CYS B 79 1555 1555 2.91 SSBOND 3 CYS B 117 CYS B 173 1555 1555 2.02 SSBOND 4 CYS D 107 CYS D 163 1555 1555 2.03 SSBOND 5 CYS E 15 CYS E 79 1555 1555 2.82 SSBOND 6 CYS E 117 CYS E 173 1555 1555 2.02 LINK ND2 ASN A 78 C1 NAG A 202 1555 1555 1.44 LINK ND2 ASN A 118 C1 NAG A 201 1555 1555 1.44 LINK ND2 ASN D 78 C1 NAG D 201 1555 1555 1.44 LINK ND2 ASN D 118 C1 NAG D 202 1555 1555 1.44 CISPEP 1 ASN A 15 PRO A 16 0 1.49 CISPEP 2 THR A 113 PRO A 114 0 1.23 CISPEP 3 TYR B 123 PRO B 124 0 2.58 CISPEP 4 SER C 100 GLN C 101 0 0.26 CISPEP 5 ASN D 15 PRO D 16 0 0.96 CISPEP 6 THR D 113 PRO D 114 0 1.22 CISPEP 7 GLY E 1 ASP E 2 0 -0.73 CISPEP 8 TYR E 123 PRO E 124 0 1.64 CISPEP 9 SER F 100 GLN F 101 0 -0.33 CRYST1 66.740 73.500 94.940 90.00 106.95 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014984 0.000000 0.004567 0.00000 SCALE2 0.000000 0.013605 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011011 0.00000